CardioVerse: The cardiovascular medicine in the era of Metaverse

Trends Cardiovasc Med. 2023 Nov;33(8):471-476. doi: 10.1016/j.tcm.2022.05.004. Epub 2022 May 11.

Abstract

The recent pandemic launched an acceleration in adopting telemedicine by cardiovascular health and triggered the flourishing of technological advancements, such as the metaverse, which is a novel interactive mix of digital worlds that leverages augmented reality with virtual reality. The CardioVerse represents a theoretical term for the embracement of the metaverse by cardiovascular medicine, encompassing the endless possibilities as well as the challenges that it holds and introduces new dimensions to disease education, prevention and diagnosis. Its applications are numerous, notably in enhancing medical visits, assisting cardiovascular interventions and reshaping the way medical education is provided. Although obstacles are expected in diverse domains such as security, technical, legislative and regulatory, the utilization of non-fungible tokens as a security asset for patient data appears as potential solution.

Keywords: Augmented reality; Education; Metaverse; Non-fungible tokens; Telemedicine; Virtual reality.

Publication types

  • Review

MeSH terms

  • Augmented Reality*
  • Cardiovascular Agents*
  • Education, Medical*
  • Humans
  • Pandemics
  • Telemedicine*

Substances

  • Cardiovascular Agents